Indeed, it has been shown that the downmodulation of Blimp1 in solid tumors leads to impaired cell migration both in non-small cell lung cancer and in ERα positive breast cancer cell lines, where Blimp1 represses the BMP5 protein16, 18. This evidence concerns the gene BMP5 and breast carcinoma.